Evidence map›Paper›PMID 27484718›Full record

ArticleBMC veterinary research2016

Effects and synergy of feed ingredients on canine neoplastic cell proliferation.

Corri B Levine, Julie Bayle, Vincent Biourge, Joseph J Wakshlag

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Frontiers in oncology · 2026
    Article
  3. Review
  4. Anti-Cancer Activity ofMarine drugs · 2025
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Corri B LevineDepartment of Clinical Sciences, Cornell University College of Veterinary Medicine, Veterinary Medical Center C2-009, Ithaca, 14853, NY, USA.
Julie BayleRoyal Canin Research Center, Airmargues, France.
Vincent BiourgeRoyal Canin Research Center, Airmargues, France.
Joseph J WakshlagDepartment of Clinical Sciences, Cornell University College of Veterinary Medicine, Veterinary Medical Center C2-009, Ithaca, 14853, NY, USA. jw37@cornell.edu.
Cornell University · USNew York State College of Veterinary Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdjunctive use of nutraceuticals in human cancer has shown promise, but little work has been done in canine neoplasia. Previous human research has shown that polyphenols and carotenoids can target multiple pathways in vitro and in vivo. These compounds could synergize or antagonize with currently used chemotherapies, either increasing or decreasing the effectiveness of these drugs. Considering the routine and well controlled feeding practices of most dogs, the use of nutraceuticals incorporated into pet food is attractive, pending proof that the extracts are able to improve remission rates. The aim of this study was to examine five feed ingredients for antiproliferative effects, as well as the interaction with toceranib phosphate and doxorubicin hydrochloride, when treating canine neoplastic cell lines in vitro.

resultsScreening using MTT proliferation assays showed that green tea, turmeric, and rosemary extracts were the most effective. Turmeric extract (TE) was the most potent and exhibited synergy with a rosemary extract (RE) at concentrations from 1 to 25 μg mL(-1). This combination had an additive or synergistic effect with chemotherapeutic agents at selected concentrations within each cell line. No significant effects on cell viability were observed when the combination therapy was used with normal primary cells.

conclusionsThe use of turmeric and rosemary extracts in combination may be worthwhile to investigate in the pre-clinical and clinical neoplastic considering there are no negative effects on traditional chemotherapy treatment. Further studies into the pharmacokinetics and mechanisms of action of these extracts should be investigated.

Indexed as

Drug SynergismAnimal FeedAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationCell SurvivalDietDogsDoxorubicinIndolesPlant ExtractsPyrrolesAntineoplastic AgentsDoxorubicinIndolesPlant ExtractsPyrrolestoceranib phosphateCanine cancerCell proliferationCurcuminMammary carcinomaMastocytomaOsteosarcomaRosemary

Identifiers

PMID27484718
PMCPMC4970212
OpenAlexW2502525057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.